154 related articles for article (PubMed ID: 2888855)
1. The cardiovascular actions of dopexamine hydrochloride, an agonist at dopamine receptors and beta 2-adrenoceptors in the dog.
Smith GW; Hall JC; Farmer JB; Simpson WT
J Pharm Pharmacol; 1987 Aug; 39(8):636-41. PubMed ID: 2888855
[TBL] [Abstract][Full Text] [Related]
2. Contrasting effects of dopexamine hydrochloride on electrolyte excretion in canine kidney.
Bass AS
J Pharmacol Exp Ther; 1990 May; 253(2):798-802. PubMed ID: 1971021
[TBL] [Abstract][Full Text] [Related]
3. Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.
Brown RA; Dixon J; Farmer JB; Hall JC; Humphries RG; Ince F; O'Connor SE; Simpson WT; Smith GW
Br J Pharmacol; 1985 Jul; 85(3):599-608. PubMed ID: 2862944
[TBL] [Abstract][Full Text] [Related]
4. The effects of dopexamine on the cardiovascular system of the dog.
Brown RA; Farmer JB; Hall JC; Humphries RG; O'Connor SE; Smith GW
Br J Pharmacol; 1985 Jul; 85(3):609-19. PubMed ID: 4027482
[TBL] [Abstract][Full Text] [Related]
5. An introduction to the pharmacologic properties of Dopacard (dopexamine hydrochloride).
Smith GW; O'Connor SE
Am J Cardiol; 1988 Aug; 62(5):9C-17C. PubMed ID: 2900602
[TBL] [Abstract][Full Text] [Related]
6. [Dopexamine: a new dopaminergic agonist].
Perrin G; Papazian L; Martin C
Ann Fr Anesth Reanim; 1993; 12(3):308-20. PubMed ID: 7902685
[TBL] [Abstract][Full Text] [Related]
7. Inotropic mechanisms of dopexamine hydrochloride in horses.
Muir WW
Am J Vet Res; 1992 Aug; 53(8):1343-6. PubMed ID: 1354950
[TBL] [Abstract][Full Text] [Related]
8. Changes in cardiovascular responsiveness to dopexamine and beta 1- and beta 2-adrenoceptor function after the chronic treatment of beta-adrenoceptor antagonists and agonists in anaesthetized dogs.
Chang DH; Einstein R
J Auton Pharmacol; 1996 Oct; 16(5):269-79. PubMed ID: 9023671
[TBL] [Abstract][Full Text] [Related]
9. Relative significance of dopamine receptors, beta adrenoceptors and norepinephrine uptake inhibition in the cardiovascular actions of dopexamine hydrochloride.
Goldberg LI; Bass AS
Am J Cardiol; 1988 Aug; 62(5):37C-40C. PubMed ID: 2841837
[TBL] [Abstract][Full Text] [Related]
10. Reduced effects of dopexamine on force of contraction in the failing human heart despite preserved beta 2-adrenoceptor subpopulation.
Böhm M; Pieske B; Schnabel P; Schwinger R; Kemkes B; Klövekorn WP; Erdmann E
J Cardiovasc Pharmacol; 1989 Oct; 14(4):549-59. PubMed ID: 2478768
[TBL] [Abstract][Full Text] [Related]
11. Presynaptic effects of dopexamine hydrochloride in the canine kidney.
Bass AS
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):33-6. PubMed ID: 1347154
[TBL] [Abstract][Full Text] [Related]
12. Dopexamine hydrochloride. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in acute cardiac insufficiency.
Fitton A; Benfield P
Drugs; 1990 Feb; 39(2):308-30. PubMed ID: 1970288
[TBL] [Abstract][Full Text] [Related]
13. Anatomical localization of the binding and functional characterization of responses to dopexamine hydrochloride in the rat mesenteric vasculature.
Amenta F; Ricci A; Napoleone P; Vyas SJ; Lokhandwala MF
Pharmacology; 1991; 42(4):211-22. PubMed ID: 1677201
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the effects of dopexamine, a novel DA1 receptor and beta 2-adrenoceptor agonist, on cardiac function and splanchnic circulation in a canine model of hemorrhagic shock.
Chintala MS; Moore RJ; Lokhandwala MF; Jandhyala BS
Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):296-300. PubMed ID: 8097568
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular actions of dopexamine in anaesthetized and conscious dogs.
Einstein R; Abdul-Hussein N; Wong TW; Chang DH; Matthews R; Richardson DP
Br J Pharmacol; 1994 Jan; 111(1):199-204. PubMed ID: 7912154
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog.
Bass AS; Kohli JD; Lubbers N; Goldberg LI
J Pharmacol Exp Ther; 1987 Sep; 242(3):940-4. PubMed ID: 2888876
[TBL] [Abstract][Full Text] [Related]
17. Effects of dopexamine on hemodynamics and oxygen consumption after beta blockade in lambs.
Taylor BJ; Rogers BW; Sziszak TL; Sziszak TJ
Crit Care Med; 1993 May; 21(5):733-9. PubMed ID: 8386999
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and renal haemodynamic effects of dopexamine: comparison with dopamine.
Stephan H; Sonntag H; Henning H; Yoshimine K
Br J Anaesth; 1990 Sep; 65(3):380-7. PubMed ID: 1977432
[TBL] [Abstract][Full Text] [Related]
19. Studies on the pharmacological interventions to prevent oxygen free radical (OFR)-mediated toxicity; effects of dopexamine, a DA1 receptor and beta 2 adrenoceptor agonist.
Jacinto SM; Lokhandwala MF; Jandhyala BS
Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):277-83. PubMed ID: 7824044
[TBL] [Abstract][Full Text] [Related]
20. Dopexamine hydrochloride in the human kidney: localization, receptor binding and effect on 3'-5'-cyclic adenosine monophosphate generation.
Napoleone P; Cavallotti C; Ricci A; Amenta F
Nephron; 1993; 65(3):385-91. PubMed ID: 7904730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
